Pharmacophore modeling: 1 - methods

Comprehensive Medicinal Chemistry II

Volumn 4, Issue , 2006, Pages 119-147

  Martin, Y C ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84906460724     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (192)

1. Gund, P. Prog. Mol. Subcell. Biol. 1977, 5, 117-143.
2. Kier, L. B. Molecular Conformation. Molecular Orbital Theory in Drug Research'; Academic Press: New York, 1971, pp 164-195.
3. Dror, O.; Shulman, P. A.; Nussinov, R.; Wolfson, H. J. Curr. Med. Chem. 2004, 11, 71-90.
4. Van Drie, J. H. Curr. Pharm. Des. 2003, 9, 1649-1664.
5. Güner, O. F. Pharmacophore Perception, Development, and Use in Drug Design; International University Line: La Jolla, CA, 1999, p. 537.
6. Cottrell, S. J.; Gillet, V J.; Taylor, R.; Wilton, D. J. J. Gomput.-AidedMol. Des. 2004, 18, 665-682.
7. Seeman, P; Watanabe, M.; Grigoriadis, D.; Tedesco, J. L.; George, S. R.; Svensson, U.; Lars, J.; Nilsson, G.; Neumeyer, J. L. Mol. Pharmacol. 1985, 28, 391-399.
8. McDermed, J. D.; Freeman, H. S.; Ferris, R. M. Enantioselective Binding of (+) and (-) 2-Amino-6,7-Dihydroxy-1, 2,3,4-Tetrahydro-naphthalenes and Related Agonists to Dopamine Receptors. In Catecholamines: Basic and Clinical Frontiers; Usdin, E., Ed.; Pergamon: New York, 1979, p 568.
9. Booher, R. N.; Kornfeld, E. C.; Smalstig, E. B.; Clemens, J. A. J. Med. Chem. 1987, 30, 580-583.
10. Jaen, J. C.; Caprathe, B. W; Wise, L. D.; Pugsley, T A.; Meltzer, L. T; Heffner, T. G. Bioorg. Med. Chem. Lett. 1991, 1, 539-544.
11. Weinstock, J.; Gaitanopoulos, D. E.; Stringer, O. D.; Franz, R. G.; Hieble, J. P.; Kinter, L. B.; Mann, W A.; Flaim, K. E.; Gessner, G. J. Chem. 1987, 30, 1166-1176.
12. Li, H.; Sutter, J.; Hoffman, R. HypoGen: An Automated System for Generating 3D Predictive Pharmacophore Models. In Pharmacophore Perception, Development, and Use in Drug Design; Güner, O. F, Ed.; International University Line: La Jolla, CA, 1999; pp 171-189.
13. Kubinyi, H. DrugDisc. Today 1997, 2, 457-467.
14. Kubinyi, H. Drug Disc. Today 1997, 2, 538-546.
15. Sufrin, J. R.; Dunn, D. A.; Marshall, G. R. Mol. Pharmacol. 1981, 19, 307-313.
16. Pauling, L.; Delbrück, M. Science 1940, 92, 77-79.
17. Taylor, R.; Kennard, O. Acc. Chem. Res. 1984, 17, 320-326.
18. Mayer, D.; Naylor, C. B.; Motoc, I.; Marshall, G. R. J. Comput.-AidedMol. Des. 1987, 1, 3-16.
19. Allen, F H. Acta Crystallogr. 2002, B58, 380-388.
20. Allen, F H.; Kennard, O.; Taylor, R. Acc. Chem. Res. 1983, 16, 146-153.
21. Lommerse, J. P. M.; Stone, A. J.; Taylor, R.; Allen, F H. J. Am. Chem. Soc. 1996, 118, 3108-3116.
22. Bruno, I. J.; Cole, J. C.; Lommerse, J.; Rowland, R. S.; Taylor, R.; Verdonk, M. L. J. Comput.-Aided Mol. Des. 1997, 11, 525-537.
23. Lommerse, J.; Taylor, R. J. Enzyme Inhib. 1997, 11.
24. Nobeli, I.; Price, S. L.; Lommerse, J.; Taylor, R. J. Comput. Chem. 1997, 18, 2060-2074.
25. Pitchford, N.; Taylor, R. Crystallographic Databases and Their Use for Studying Intermolecular Interactions. In Designing Bioactive Molecules: Three-Dimensional Techniques; Martin, Y C., Willett, P, Eds.; American Chemical Society: Washington DC, 1997, pp 19-46.
26. Mills, J.; Dean, P. M. J. Comput.-Aided Mol Des. 1996, 10, 607-622.
27. Crippen, G. Distance Geometry and Conformational Calculations; Research Studies Press: Letchworth, 1981, p 53.
28. Allinger, M. L. MMP2; Tripos Inc: St Louis, MO, 1995.
29. DISCOVER; Molecular Simulations: San Diego, CA, 1992.
30. Sybyl Molecular Modeling Software; TRIPOS, Inc.: St. Louis, MO, 1995.
31. Jorgensen, W L.; Maxwell, D. S.; Tiradorives, J. J. Am. Chem. Soc. 1996, 118, 11225-11236.
32. Beachy, M. D.; Chasman, D.; Murphy, R. B.; Halgren, T A.; Friesner, R. A. J. Am. Chem. Soc. 1997, 119, 5908-5920.
33. Perola, E.; Charifson, P S. J. Med. Chem. 2004, 47, 2499-2510.
34. Halgren, T A. J. Comput. Chem. 1996, 17, 490-519.
35. Halgren, T A. J. Comput. Chem. 1996, 17, 520-552.
36. Halgren, T A. J. Comput. Chem. 1996, 17, 616-641.
37. Halgren, T A. J. Comput. Chem. 1996, 17, 553-586.
38. Halgren, T A.; Nachbar, R. B. J. Comput. Chem. 1996, 17, 587-615.
39. Omega, OpenEye Scientific Software, 3600 Cerrillos Rd., Suite 1107: Santa Fe, NM, 87507, USA. www.eyesopen.com/products/applications/omega.html (accessed May 2006).
40. Kristam, R.; Gillet, V J.; Lewis, R. A.; Thorner, D. J. Chem. Inf. Model. 2005, 45, 461-476.
41. Mason, J. S.; Morize, I.; Menard, P. R.; Cheney, D. L.; Hulme, C.; Labaudiniere, R. F. J. Med. Chem. 1999, 42, 3251-3264.
42. Cramer, R. D., III.; Patterson, D. E.; Bunce, J. D. J. Am. Chem. Soc. 1988, 110, 5959-5967.
43. Bersuker, I. B.; Bahceci, S.; Boggs, J. E.; Pearlman, R. S. J. Comput.-Aided Mol. Des. 1999, 13, 419-434.
44. Bersuker, I. B.; Bahçeci, S.; Boggs, J. E. J. Chem. Inf. Comput. Sci. 2000, 40, 1363-1376.
45. Bersuker, I. B. Curr. Pharm. Des. 2003, 9, 1575-1606.
46. Crippen, G. M. J. Comp. Phys. 1977, 24, 96-107.
47. Jakes, S. E.; Willett, P J. Mol. Graph. Model. 1986, 4, 12-20.
48. Clark, D. E.; Willett, P.; Kenny, P.W J. Mol. Graph. Model 1992, 10, 194-204.
49. Clark, D. E.; Willett, P.; Kenny, P.W J. Mol. Graph. Model. 1993, 11, 146-156.
50. Davies, K., Upton, R. Network Science 1995, 1. http://www.awod.com (accessed May 2006).
51. Pickett, S. D.; Mason, J. S.; Mclay, I. M. J. Chem. Inf. Comput. Sci. 1996, 36, 1214-1223.
52. Mason, J. S., Cheney, D. L. Pac Symp. Biocomput. 1999, 456-467.
53. Bradley, E. K.; Beroza, P; Penzotti, J. E.; Grootenhuis, P D.; Spellmeyer, D. C.; Miller, J. L. J. Med. Chem. 2000, 43, 2770-2774.
54. Abrahamian, E.; Fox, P C.; Naerum, L.; Christensen, I. T; Thprgersen, H.; Clark, R. D. J. Chem. Inf. Comput. Sci. 2003, 43, 458-468.
55. Poirrette, A. R.; Willett, P; Allen, F H. J. Mol. Graph. Model. 1991, 9, 203-217.
56. Feng, J.; Sanil, A.; Young, S. S. J. Chem. Inf. Model. 2006, 46, 1352-1359.
57. Chen, X.; Rusinko, A.; Tropsha, A.; Young, S. S. J. Chem. Inf Comput. Sci. 1999, 39, 887-896.
58. Marshall, G. R.; Barry, C. D.; Bosshard, H. E.; Dammkoehler, R. A.; Dunn, D. A. The Conformation Parameter in Drug Design: The Active Analog Approach. In Computer-Assisted Drug Design; Olson, E. C., Christoffersen, R. E., Eds.; American Chemical Society: Washington, 1979, pp 205-226.
59. Dammkoehler, R. A.; Karasek, S. F; Shands, E. F; Marshall, G. R. J. Comput.-Aided Mol. Des. 1989, 3, 3-21.
60. Beusen, D. D.; Marshall, G. R. Pharmacophore Definition Using the Active Analog Approach. In Pharmacophore Perception, Development, and Use in Drug Design; Guner, O., Ed.; International University Line: La Jolla, CA, 1999, pp 21-45.
61. Dammkoehler, R. A.; Karasek, S. F; Shands, E.; Marshall, G. R. J. Comput.-Aided Mol. Des. 1995, 9, 491-499.
62. Beusen, D. D.; Shands, E.; Karasek, S. F; Marshall, G. R.; Dammkoehler, R. A. J. Mol. Struct.-Theochem. 1996, 370, 2-3.
63. Van Drie, J. H. J. Comput.-Aided Mol. Des. 1997, 11, 39-52.
64. Sheridan, R. P.; Nilakantan, R.; Dixon, J. S.; Venkataraghavan, R. J. Med. Chem. 1986, 29, 899-906.
65. Metropolis, R.; Rosenbluth, A.; Teller, A.; Teller, E. J. Chem. Phys. 1953, 21, 1087-1092.
66. Barakat, M. T; Dean, P M. J. Comput.-Aided Mol. Des. 1990, 4, 295-316.
67. Hodgkin, E. E.; Miller, A.; Whittaker, M. J. Comput.-Aided Mol. Des. 1993, 7, 515-534.
68. Manly, B. F. J. Multivariate Statistical Methods. A Primer, 2nd ed.; Chapman and Hall: London, 1994, p 215.
69. Cosentino, U.; Moro, G.; Pitea, D.; Scolastico, S.; Todeschini, R.; Scolastico, C. J. Comput.-Aided Mol. Des. 1992, 6, 47-60.
70. Kato, Y; Inoue, A.; Yamada, M.; Tomioka, N.; Itai, A. J. Comput.-Aided Mol. Des. 1992, 6, 475-486.
71. Kato, Y; Itai, A.; Iitaka, Y Tetrahedron 1987, 43, 5229-5234.
72. Brint, A. T; Willett, P. J. Chem. Inf Comput. Sci. 1987, 27, 152-158.
73. Takahashi, Y; Maeda, S.; Sasaki, S.-I. Anal. Chim. Acta 1987, 200, 363-377.
74. Takahashi, Y; Akagi, T; Sasaki, S.-I. Tetrahedron Comput. Methodol. 1990, 3, 27-35.
75. Martin, Y C.; Bures, M. G.; Danaher, E. A.; DeLazzer, J.; Lico, I.; Pavlik, P. A. J. Mol. Des. 1993, 7, 83-102.
76. Golender, V. E.; Vorpagel, E. R. Computer-Assisted Pharmacophore Identification. In 3D QSAR in Drug Design. Theory Methods and ; Kubinyi, H., Ed.; ESCOM: Leiden, 1993, pp 137-149.
77. Vorpagel, E. R.; Golender, V E. Apex-3D: Activity Prediction Expert System with 3D QSAR. In Pharmacophore Perception, Development, and Use in Drug Design; Güner, O. F., Ed.; International University Line: La Jolla, CA, 1999, pp 128-149.
78. Holland, J. H. Sei. Am. 1992, 267, 66-72.
79. Payne, A. W. R.; Glen, R. C. J. Mol. Graph. Model. 1993, 11, 74-91.
80. Jones, G.; Willett, P; Glen, R. C. GASP: Genetic Algorithm Superimposition Program. In Pharmacophore Perception, Development, and Use in Drug Design; Güner, O. F., Ed.; International University Line: La Jolla, CA, 1999, pp 85-107.
81. Handschuh, S.; Gasteiger, J. J. Mol. Model. 2000, 6, 358-378.
82. Clark, R. D. Galahad; Tripos: St. Louis, MO, USA. www.tripos.com (accessed May 2006).
83. Wold, S.; Ruhe, A.; Wold, H.; Dunn, W J. SIAM J. Sei. Stat. Comput. 1984, 5, 735-743.
84. Hoskuldsson, A. J. Chemometr. 1988, 2, 211-228.
85. Bro, R. J. Chemometr. 1996, 10, 47-61.
86. Hasegawa, K.; Arakawa, M.; Funatsu, K. Comput. Biol. Chem. 2003, 27, 211-216.
87. Hopfinger, A. J.; Wang, S.; Tokarski, J. S.; Jin, B. Q.; Albuquerque, M.; Madhav, P J.; Duraiswami, C. J. Am. Chem. Soc. 1997,119, 10509-10524.
88. Hawkins, D. M.; Young, S. S.; Rusinko, A. Quant. Struct.-Act. Relat. 1997, 16, 296-302.
89. Chen, X.; Rusinko, A.; Young, S. S. J. Chem. Inf. Comput. Sei. 1998, 38, 1054-1062.
90. Young, S. S.; Hawkins, D. M. SAR QSAR Environ. Res. 1998, 8, 183-193.
91. Lawrence, C. E.; Altschul, S. F; Boguski, M. S.; Liu, J. S.; Neuwald, A. F; Wootton, J. C. Science 1993, 262, 208-214.
92. Crippen, G. M. J. Med. Chem. 1997, 40, 3161-3172.
93. Boulu, L. G.; Crippen, G. M.; Barton, H. A.; Kwon, H.; Marletta, M. A. J. Med. Chem. 1990, 33, 771-775.
94. Srivastava, S.; Richardson, W W; Bradley, M. P.; Crippen, G. M. Three-Dimensional Receptor Modeling Using Distance Geometry and Voronoi Polyhedra. In 3D QSAR in Drug Design. Theory Methods and Applications; Kubinyi, H., Ed.; ESCOM: Leiden, 1993, pp 409-430.
95. http://www.accelrys.com/products/catalyst/(accessed July 2006).
96. Phase, Schrüdinger, 120 W 45th St.: New York, NY 10036-4041.
97. Kearsley, S. K., Smith, G. M. Seal. An Alternate Method for the Alignment of Molecular Structures, Qepe 634, Quantum Chemistry Program Exchange, Indiana University: Bloomington, IN 47405.
98. Nissink, J. W M.; Verdonk, M. L.; Kroon, J.; Mietzner, T; Klebe, G. J. Comput. Chem. 1997, 18, 638-645.
99. Lemmen, C.; Lengauer, T; Klebe, G. J. Med. Chem. 1998, 41, 4502-4520.
100. Lemmen, C.; Lengauer, T J. Comput.-Aided Mol. Des. 1997, 11, 357-368.
101. Miller, M. D.; Sheridan, R. P; Kearsley, S. K. J. Med. Chem. 1999, 42, 1505-1514.
102. Weber, P. C.; Wendoloski, J. J.; Pantoliano, M. W; Salemme, F R. J. Am. Chem. Soc. 1992, 114, 3197-3200.
103. Weichsel, A.; Montfort, W R. Nat. Struct. Biol 1995, 2, 1095-1101.
104. Verkhivker, G. M.; Bouzida, D.; Gehlhaar, D. K.; Rejto, P. A.; Freer, R. J.; Rose, P. W Curr. Opin. Struct. Biol. 2002, 12, 197-203.
105. Birch, L.; Christopher, W M.; Michael, J. H.; Ian, J. T.; Marcel, L. V J. Comput.-Aided Mol. Des. 2002, 16, 855-869.
106. Erickson, J. A.; Jalaie, M.; Robertson, D. H.; Lewis, R. A.; Vieth, M. J. Med. Chem. 2004, 47, 45-55.
107. Daeyaert, F.; de Jonge, M.; Heeres, J.; Koymans, L.; Lewi, P; Vinkers, M. H.; Janssen, P A. J. Proteins 2004, 54, 526-533.
108. Horton, J. R.; Sawada, K.; Nishibori, M.; Cheng, X. J. Mol. Biol. 2005, 353, 334-344.
109. Cavasotto, C. N.; Abagyan, R. A. J. Mol. Biol. 2004, 337, 209-225.
110. Brenk, R.; Meyer, E. A.; Reuter, K.; Stubbs, M. T; Garcia, G. A.; Diederich, F.; Klebe, G. J. Mol. Biol. 2004, 338, 55-75.
111. Gao, F; Bren, N.; Little, A.; Wang, H. L.; Hansen, S. B.; Talley, T T; Taylor, P; Sine, S. M. J. Biol. Chem. 2003, 278, 23020-23026.
112. Sine, S. M.; Wang, H. L.; Gao, F Curr. Med. Chem. 2004, 11, 559-567.
113. Fritz, T. A.; Tondi, D.; Finer-Moore, J. S.; Costi, M. P; Stroud, R. M. Chem. Biol. 2001, 8, 981-995.
114. Espinosa, J. F; Canada, F. J.; Asensio, J. L.; Dietrich, H.; Martinlomas, M.; Schmidt, R. R.; Jimenezbarbero, J. Angew. Chem. Int. Ed. 1996, 35, 303-306.
115. Gruneberg, S.; Stubbs, M. T; Klebe, G. J. Med. Chem. 2002, 45, 3588-3602.
116. Moitessier, N.; Henry, C.; Maigret, B.; Chapleur, Y J. Med. Chem. 2004, 47, 4178-4187.
117. Lauri, G.; Bartlett, P. A. J. Comput.-Aided Mol. Des. 1994, 8, 51-66.
118. Bartlett, P A.; Shea, G. T; Telfer, S. J.; Waterman, S. CAVEAT: A Program to Facilitate the Structure-Derived Design of Biologically Active Molecules. In Chemical and Biological Problems in Molecular Recognition; Roberts, S. M., Ley, S. V, Campbell, M. M., Eds.; Roy. Soc. Chem.: Cambridge, 1989, pp 182-196.
119. Willett, P. J. Mol. Recognit. 1995, 8, 290-303.
120. Thorner, D. A.; Willett, P; Wright, P. M.; Taylor, R. J. Comput.-Aided Mol Des. 1997, 11, 163-174.
121. Thorner, D. A.; Wild, D. J.; Willett, P.; Wright, P M. J. Chem. Inf. Comput. Sei. 1996, 36, 900-908.
122. Wang, X.; Wang, J. T. L. J. Chem. Inf. Comput. Sei. 2000, 40, 442-451.
123. Good, A. C. Internet Journal of Chemistry 2000, 3, NIL 3-NIL 21.
124. Makara, G. M. J. Med. Chem. 2001, 44, 3563-3571.
125. Irwin, J. J.; Shoichet, B. K. J. Chem. Inf. Model 2005, 45, 177-182.
126. Iresearch Library, ChemNavigator: San Diego, CA. http://www.chemnavigator.com (accessed May 2006).
127. NCI DTP/2D and 3D Structural Information. gov/docs/3ddatabase/structuralinformation/structuraldata.html (accessed May 2006).
128. Voigt, J. H.; Bienfait, B.; Wang, S.; Nicklaus, M. C. J. Chem. Inf. Comput. Sei. 2001, 41, 702-712.
129. Van Drie, J. H.; Nugent, R. A. SAR QSAR Environ. Res. 1998, 9, 1062-1936X.
130. Andrews, K. M.; Cramer, R. D. J. Med. Chem. 2000, 43, 1723-1740.
131. Cramer, R. D. J. Med. Chem. 2003, 46, 374-388.
132. WDI: World Drug Index, Derwent: London.
133. ACD: Available Chemicals Directory; Elsevier MDL, San Ramon, CA.
134. Nilakantan, R.; Bauman, N.; Haraki, K. S. J. Comput.-Aided Mol. Des. 1997, 11, 447-452.
135. Rishton, G. M. Drug Disc. Today 1997, 2, 382-384.
136. Lipinski, C. A.; Lombardo, F; Dominy, B. W; Feeney, P. J. Adv. Drug Deliv. Rev. 1997, 23, 3-25.
137. Rusinko, A., III.; Sheridan, R. P; Nilakantan, R.; Haraki, K. S.; Bauman, N.; Venkataraghavan, R. J. Chem. Inf. Comput. Sci. 1989, 29, 251-255.
138. Rusinko, A. I.; Skell, J. M.; Balducci, R.; McGarity, C. M.; Pearlman, R. S. Concord, a Program for the Rapid Generation of High Quality Approximate3-Dimensional Molecular Structures, 3.01 ed.; The University of Texas at Austin and Tripos Associates: St. Louis, Missouri.
139. ISIS: Elsevier MDL, San Ramon, CA.
140. Weininger, D.; Weininger, A. J. Chem. Inf. Comput. Sci. 1988, 28, 31-36.
141. Weininger, D.; Weininger, A.; Weininger, J. L. J. Chem. Inf. Comput. Sci. 1989, 29, 97-101.
142. Ash, S.; Cline, M. A.; Homer, R. W; Hurst, T; Smith, G. B. J. Chem. Inf. Comput. Sci. 1997, 37, 71-79.
143. Gasteiger, J.; Rudolph, C.; Sadowski, A. Tetrahedron Comput. Methodol 1992, 3, 537-547.
144. Sadowski, J.; Gasteiger, J. Chem. Rev. 1993, 93, 2567-2581.
145. Ricketts, E. M.; Bradshaw, J.; Hann, M.; Hayes, F; Tanna, N.; Ricketts, D. M. J. Chem. Inf. Comput. Sci. 1993, 33, 905-925.
146. Sadowski, J.; Gasteiger, J.; Klebe, G. J. Chem. Inf. Comput. Sci. 1994, 34, 1000-1008.
147. Stereoplex and Protoplex, Tripos: St. Louis, MO. www.tripos.com (accessed May 2006).
148. Haraki, K. S.; Sheridan, R. P; Venkataraghavan, R. Tetrahedron Comput. Methodol. 1990, 3, 565-573.
149. Huber, T; Torda, A. E.; van Gunsteren, W F J. Comput.-Aided Mol. Des. 1994, 8, 695-708.
150. Smellie, A.; Teig, S. L.; Towbin, P J. Comput. Chem. 1995, 16, 171-187.
151. Boström, J. J. Comput.-Aided Mol. Des. 2001, 15, 1137-1152.
152. Boström, J.; Greenwood, J. R.; Gottfries, J. J. Mol. Graph. Model. 2003, 21, 449-462.
153. Confort; Tripos, Inc.: St. Louis, MO.
154. Rotate; Molecular Networks GmbH: Erlangen, Germany.
155. Hurst, T J. Chem. Inf. Comput. Sci. 1994, 34, 190-196.
156. Moock, T. E.; Henry, D. R.; Ozkabak, A. G.; Alamgir, M. J. Chem. Inf. Comput. Sci. 1994, 34, 184-189.
157. Murrall, N. W; Davies, E. K. J. Chem. Inf. Comput. Sci. 1990, 30, 312-316.
158. Clark, D. E., Jones, G., Willett, Kenny, P W, Glen, R. C., J. Chem. Inf. Comput. Sci. 1994,34, 197-206.
159. ROCS, OpenEye Scientific Software: Santa Fe, NM. http://www.eyesopen.com/products/applications/rocs.html (accessed May 2006).
160. Unity Chemical Information Software, Tripos Associates: St. Louis, MO. www.tripos.com (accessed May 2006).
161. Sprague, P W Perspect. Drug Disc. Des. 1995, 3, 1-20.
162. Grant, J. A.; Gallardo, M. A.; Pickup, B. T J. Comput. Chem. 1996, 17, 1653-1666.
163. Waszkowycz, B.; Clark, D. E.; Frenkel, D.; Li, J.; Murray, C. W; Robson, B.; Westhead, D. R. J. Med. Chem. 1994, 37, 3994-4002.
164. Takahasi, Y; Akagi, T; Sasaki, S.-I. Tetrahedron Comput. Methodol. 1990, 3, 27-35.
165. Perkins, T D. J.; Dean, P M. J. Comput.-Aided Mol Des. 1993, 7, 155-172.
166. Barnum, D.; Greene, J.; Smellie, A.; Sprague, P. J. Chem. Inf. Comput. Sci. 1996, 36, 563-571.
167. Clement, O. O.; Mehl, A. T Hiphop: Pharmacophores Based on Multiple Common Feature Alignments. In Pharmacophore Perception, Development, and Use in Drug Design; Güner, O., Ed.; International University Line: La Jolla, CA, 1999, pp 69-84.
168. Jones, G.; Willett, P.; Glen, R. C. J. Comput.-Aided Mol. Des. 1995, 9, 532-549.
169. Holliday, J. D.; Willett, P J. Mol. Graph. Model 1997, 15, 221-232.
170. Handschuh, S.; Wagener, M.; Gasteiger, J. J. Chem. Inf. Comput. Sci. 1998, 38, 220-232.
171. Huang, P.; Kim, S.; Loew, G. J. Comput.-Aided Mol. Des. 1997, 11, 21-28.
172. Cosentino, U.; Moro, G.; Pitea, D.; Todeschini, R.; Brossa, S.; Gualandi, F; Scolastico, C.; Giannessi, F Quant. Stuct.-Act. 1990, 9, 195-201.
173. Jain, A. N.; Dietterich, T G.; Lathrop, R. H.; Chapman, D.; Critchlow, R. E., Jr.; Bauer, B. E.; Webster, T A.; Lozano-Perez, T J. Comput.-Aided Mol. Des. 1994, 8, 635-652.
174. Jain, A. N.; Koile, K.; Chapman, D. J. Med. Chem. 1994, 37, 2315-2327.
175. Jain, A. N.; Harris, N. L.; Park, J. Y J. Med. Chem. 1995, 38, 1295-1308.
176. Chapman, D.; Critchlow, R.; Jain, A. N.; Lathrop, R.; Perez, T L.; Dietterich, T Machine-Learning Approach to Modeling Biological Activity for Molecular Design and to Modeling Other Characteristics; Arris Pharmaceutical Corporation: US, 1996.
177. Putta, S.; Landrum, G. A.; Penzotti, J. E. J. Med. Chem. 2005, 48, 3313-3318.
178. Marchand, G. N.; Watson, K. A.; Alsberg, B. K.; King, R. D. J. Med. Chem. 2002, 45, 399-409.
179. Allen, F H.; Davies, J. E.; Galloy, J. J.; Johnson, O.; Kennard, O.; Macrea, C. F; Mitchell, E. M.; Mitchell, G. F; Smith, J. M.; Watson, D. G. J. Chem. Inf. Comput. Sci. 1991, 31, 187-204.
180. Jakes, S. E.; Watts, N.; Willett, P; Bawden, D.; Fisher, J. D. J. Mol. Graph. Model 1987, 5, 41-48.
181. Van Drie, J. H.; Weininger, D.; Martin, Y C. J. Comput.-Aided Mol. Des. 1989, 3, 225-251.
182. Martin, Y C.; Danaher, E. B.; May, C. S.; Weininger, D. J. Comput.-Aided Mol. Des. 1988, 2, 15-29.
183. Sheridan, R. P.; Nilakantan, R.; Rusinko, A.; Bauman, N.; Haraki, K.; Ventataraghavan, R. J. Chem. Inf. Comput. Sci. 1989, 29, 255-260.
184. Bruno, I. J.; Cole, J. C.; Edgington, P. R.; Kessler, M.; Macrae, C. F; McCabe, P.; Pearson, J.; Taylor, R. Acta Crystallogr., Sect. B: Struct. Sci. 2002, 58, 389-397.
185. Unity Chemical Information Software, Tripos Associates: St Louis, MO, 1993.
186. Güner, O. F; Hughes, D. W; Dumont, L. M. J. Chem. Inf. Comput. Sci. 1991, 31, 408-414.
187. Christie, B. D.; Henry, D. R.; Wipke, W T.; Moock, T. E. Tetrahedron Comput. Methodol. 1990, 3, 653-664.
188. Kuchner, O.; Arnold, F. H. Trends Biotechnol. 1997, 15, 523-530.
189. Kurogi, Y; Güner, O. F Curr. Med. Chem. 2001, 8, 1035-1055.
190. Greene, J.; Kahn, S.; Savoj, H.; Sprague, P.; Teig, S. J. Chem. Inf. Comput. Sci. 1994, 34, 1297-1308.
191. Hahn, M. J. Chem. Inf. Comput. Sci. 1997, 37, 80-86.
192. Andrews, K. M.; Cramer, R. D. J. Med. Chem. 2000, 43, 1723-1740.